306 filings
Page 5 of 16
8-K
7iv30jq0qfsvp ufk
27 Jun 19
Submission of Matters to a Vote of Security Holders
4:33pm
8-K
xolu7lx 9itek
19 Jun 19
Entry into a Material Definitive Agreement
7:00am
8-K
swr56qdmy
31 May 19
Amicus Therapeutics Announces Public Offering of Common Stock
5:17pm
8-K
es7r7
29 May 19
Entry into a Material Definitive Agreement
6:32am
8-K
j9g 7ikhbcz
22 May 19
Entry into a Material Definitive Agreement
7:07am
8-K
c2axnk33
21 May 19
Entry into a Material Definitive Agreement
5:16pm
8-K
i958hs5ldlt8x79s
14 May 19
Other Events
8:03am
8-K
z1epi3q2 j6
13 May 19
Amicus Therapeutics Appoints Burke W. Whitman to its Board of Directors
5:12pm
8-K
ag0k96k7
8 May 19
Amicus Therapeutics Announces First Quarter 2019 Financial Results and Corporate Updates
7:20am
8-K
nnbitp
30 Apr 19
Other Events
6:38am
8-K
xafvlg5kc ddn
20 Mar 19
Amicus Therapeutics Issued Two U.S. Patents for Pompe Enzyme ATB200
8:52am
8-K
yn6b5z5ornpw001 iub
13 Mar 19
Entry into a Material Definitive Agreement
7:31am
8-K
t4c0m6ajcnvh
28 Feb 19
Entry into a Material Definitive Agreement
5:24pm
8-K
8r6kh99p6
28 Feb 19
Amicus Therapeutics Announces Full-Year 2018 Financial Results and 2019 Corporate Updates
7:04am
8-K
vkiufzzzwcgjbfp
26 Feb 19
Other Events
7:03am
8-K
cedakjvoy28yjdx
25 Feb 19
Other Events
6:02am
8-K
0ri3lq72nn56nrd
8 Feb 19
Entry into a Material Definitive Agreement
7:03am
8-K
sgv36lj5g1hp0jz69
5 Feb 19
Other Events
4:02pm
8-K
ag8w lt7m2pploc6xp
24 Jan 19
Entry into a Material Definitive Agreement
9:13am
8-K
ryusw0cwgtr91mm0puq
18 Jan 19
Other Events
12:00am